MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Debt to Asset Ratio
59.45%
Unit: Thousand (K) dollars
Assets Breakdown
Investments, at fair value-Inves...
Restricted cash and cash equival...
Cash and cash equivalents
Others
Liabilities Breakdown
Paid-in capital in excess of par...
Debt (net of deferred financing ...
Accumulated earnings (loss)
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Investments, at fair value-Investment Unaffiliated Issuer
1,485,083
1,486,650
1,479,473
1,487,246
Investments, at fair value-Investment Affiliated Issuer Noncontrolled
31,053
21,331
29,594
30,476
Investments, at fair value-Investment Affiliated Issuer Controlled
54,532
54,489
60,351
62,956
Cash and cash equivalents
15,604
6,139
5,043
5,786
Restricted cash and cash equivalents
20,137
20,454
26,454
22,017
Interest and dividend receivable
8,214
10,944
9,333
9,932
Receivable from unsettled transactions
716
12,477
8,019
5,285
Unrealized appreciation on foreign currency forward contracts
1,255
1,806
2,135
2,082
Deferred tax assets
229
235
190
181
Other assets
2,064
3,129
1,543
1,667
Total assets
1,618,887
1,617,654
1,622,135
1,627,628
Debt (net of deferred financing costs of 9,527 and 5,841 respectively)
922,945
907,133
873,761
875,315
Distributions payable
12,528
15,497
15,527
15,557
Interest and other debt financing costs payable
12,397
8,353
12,370
7,943
Management fees payable
3,972
4,915
5,037
5,119
Incentive fees payable
2,279
1,575
3,468
3,574
Unrealized depreciation on foreign currency forward contracts
1,756
1,880
2,134
2,271
Unrealized depreciation on interest rate swaps
3,040
1,603
-
-
Deferred tax liabilities
229
235
190
181
Accrued expenses and other liabilities
3,290
2,435
3,610
3,593
Total liabilities
962,436
943,626
916,097
913,553
Common stock, par value 0.001 per share (200,000,000 shares authorized, 36,845,952 and 36,969,285 shares issued and outstanding, respectively)
37
37
37
37
Paid-in capital in excess of par value
955,363
956,030
957,030
958,765
Accumulated earnings (loss)
-298,949
-282,039
-251,029
-244,727
Total net assets
656,451
674,028
706,038
714,075
Total liabilities and net assets
1,618,887
1,617,654
1,622,135
1,627,628
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Investments, at fair
value-Investment Unaffiliated...
$1,485,083K
Investments, at fair
value-Investment Affiliated...
$54,532K
Investments, at fair
value-Investment Affiliated...
$31,053K
Restricted cash and cash
equivalents
$20,137K
Cash and cash
equivalents
$15,604K
Interest and dividend
receivable
$8,214K
Other assets
$2,064K
Unrealized appreciation on
foreign currency...
$1,255K
Receivable from unsettled
transactions
$716K
Deferred tax assets
$229K
Total assets
$1,618,887K
Total liabilities and
net assets
$1,618,887K
Total liabilities
$962,436K
Total net assets
$656,451K
Accumulated earnings (loss)
-$298,949K
Debt (net of deferred
financing costs of 9,527...
$922,945K
Distributions payable
$12,528K
Interest and other debt
financing costs payable
$12,397K
Management fees payable
$3,972K
Accrued expenses and
other liabilities
$3,290K
Unrealized depreciation on
interest rate swaps
$3,040K
Incentive fees payable
$2,279K
Unrealized depreciation on
foreign currency...
$1,756K
Deferred tax liabilities
$229K
Paid-in capital in
excess of par value
$955,363K
Common stock, par value
0.001 per share...
$37K
Buy us a coffee
Crescent Capital BDC, Inc. (CCAP)
Crescent Capital BDC, Inc. (CCAP)